Patient assistance programs (PAPs) emerged to help patients who lack health insurance or prescription drug coverage obtain ...
Additionally, there are programmes with counsellors who work with the patients to determine alternative ways to reduce a patient's cost, such as co-pay assistance, prescription saving programmes ...
But if the patient has questions about insurance coverage, the status of seeking coverage for their medication, injection training, financial assistance, even just talking through things and ...
Cancer patients, including those on patient assistance programmes, can look forward to some relief on their imported medicines. Medicines from multinational companies including Pembrolizumab (MSD ...
AbbVie ABBV announced strong fourth-quarter 2024 results last week, beating estimates for both earnings and sales. While earnings of $2.16 per share declined around 22% year over year, sales rose ...
It is likely easier for a patient ... all AbbVie needs to do to grow in value is meet its own expectations, which it typically does. Therefore, with a slight caveat in the form of some messy ...
Humira's reign has come to an end, but it's not the end for AbbVie. AbbVie’s Humira was the biopharmaceutical company's top-selling drug for two decades, generating $21 billion of revenue in ...
AbbVie made a change atop its board of directors, naming CEO Robert Michael as chairman on Friday morning. The pharma giant announced that Michael will succeed Richard A. Gonzalez, the former CEO of ...
AbbVie (NYSE: ABBV) recently released its Q4 results, with revenues and earnings comfortably above the street estimates. It reported sales of $15.1 billion and adjusted earnings of $2.16 per share ...
AbbVie ABBV has outperformed the market over the past 10 years by 2.09% on an annualized basis producing an average annual return of 13.09%. Currently, AbbVie has a market capitalization of $360. ...
AbbVie has secured its fourth FDA approval for Vraylar, adding adjunctive therapy of major depressive disorder (MDD) to a list that includes schizophrenia and manic and depressive episodes in ...